Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Overviews: 9 Aspects of this Diagnoses
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Possible Special Education
      • Possible Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • First Pages of Diagnoses from the Diagnostic and Statistical Manual and the Codes from the ICD-10 for Diagnosis and Compensation
  • Medical & Educational Downloads
  • Contact Us
Select Page

Remimazolam use in obstetric patients: a single-center retrospective study (2021-2024)

by jlohrconsulting | Sep 20, 2025 | Uncategorized

Int J Obstet Anesth. 2025 Aug 8;64:104750. doi: 10.1016/j.ijoa.2025.104750. Online ahead of print. ABSTRACT BACKGROUND: Remimazolam is an ultra-short-acting intravenous benzodiazepine approved for procedural sedation and general anaesthesia. Its favourable...

Ketamine/esketamine in the treatment of depression with comorbid borderline personality disorder or traits: A systematic review of effectiveness

by jlohrconsulting | Sep 20, 2025 | Uncategorized

Aust N Z J Psychiatry. 2025 Sep 20:48674251374472. doi: 10.1177/00048674251374472. Online ahead of print. ABSTRACT INTRODUCTION: There is mounting evidence for the use of ketamine/esketamine in the treatment of depression. This paper examines how comorbid borderline...

Natural Language Response Formats for Assessing Depression and Worry With Large Language Models: A Sequential Evaluation With Model Pre-Registration

by jlohrconsulting | Sep 20, 2025 | Uncategorized

Assessment. 2025 Sep 20:10731911251364022. doi: 10.1177/10731911251364022. Online ahead of print. ABSTRACT Large language models can transform individuals’ mental health descriptions into scores that correlate with rating scales approaching theoretical upper...

Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study

by jlohrconsulting | Sep 20, 2025 | Uncategorized

Addiction. 2025 Sep 20. doi: 10.1111/add.70187. Online ahead of print. ABSTRACT BACKGROUND & AIMS: There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient...

Dextromethorphan Bupropion Combination Tablet Suicide Attempt by Overdose: A Case Report

by jlohrconsulting | Sep 20, 2025 | Uncategorized

Neuropsychopharmacol Rep. 2025 Sep;45(3):e70060. doi: 10.1002/npr2.70060. ABSTRACT Dextromethorphan and bupropion in combination are approved to treat major depressive disorders in adults. This case report describes a patient with a history of treatment-resistant...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments